These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21314231)

  • 21. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
    LaFerla FM; Oddo S
    Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
    von Bernhardi R; Eugenín J
    Antioxid Redox Signal; 2012 May; 16(9):974-1031. PubMed ID: 22122400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and inflammation in Alzheimer's disease: close partners in disease development and progression!
    Nelson L; Gard P; Tabet N
    J Alzheimers Dis; 2014; 41(2):331-43. PubMed ID: 24614908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways towards and away from Alzheimer's disease.
    Mattson MP
    Nature; 2004 Aug; 430(7000):631-9. PubMed ID: 15295589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting ubiquilin-1 in Alzheimer's disease.
    Takalo M; Haapasalo A; Natunen T; Viswanathan J; Kurkinen KM; Tanzi RE; Soininen H; Hiltunen M
    Expert Opin Ther Targets; 2013 Jul; 17(7):795-810. PubMed ID: 23600477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development.
    Kandimalla R; Vallamkondu J; Corgiat EB; Gill KD
    Brain Pathol; 2016 Mar; 26(2):139-54. PubMed ID: 26494454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.
    Guo J; Cheng J; North BJ; Wei W
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):341-358. PubMed ID: 28694093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.
    Azizi G; Navabi SS; Al-Shukaili A; Seyedzadeh MH; Yazdani R; Mirshafiey A
    Sultan Qaboos Univ Med J; 2015 Aug; 15(3):e305-16. PubMed ID: 26357550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The search for effective Alzheimer's therapies: a work in progress.
    Bor JS
    Health Aff (Millwood); 2014 Apr; 33(4):527-33. PubMed ID: 24711310
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical aspects of Alzheimer's disease.
    Zvěřová M
    Clin Biochem; 2019 Oct; 72():3-6. PubMed ID: 31034802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.
    Cacabelos R; Cacabelos P; Torrellas C; Tellado I; Carril JC
    Methods Mol Biol; 2014; 1175():323-556. PubMed ID: 25150875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics.
    Mullane K; Williams M
    Curr Opin Pharmacol; 2019 Feb; 44():62-75. PubMed ID: 30795894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A brief review on studies of Alzheimer's disease in China: its mechanism, imaging and therapy.
    Shi H; Wang Z
    Sci China Life Sci; 2013 Dec; 56(12):1142-4. PubMed ID: 24302295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.